PLoS Pathogens (Aug 2021)

Modern Acinetobacter baumannii clinical isolates replicate inside spacious vacuoles and egress from macrophages.

  • Gabriela Sycz,
  • Gisela Di Venanzio,
  • Jesus S Distel,
  • Mariana G Sartorio,
  • Nguyen-Hung Le,
  • Nichollas E Scott,
  • Wandy L Beatty,
  • Mario F Feldman

DOI
https://doi.org/10.1371/journal.ppat.1009802
Journal volume & issue
Vol. 17, no. 8
p. e1009802

Abstract

Read online

Multidrug-resistant Acinetobacter baumannii infections are increasing at alarming rates. Therefore, novel antibiotic-sparing treatments to combat these A. baumannii infections are urgently needed. The development of these interventions would benefit from a better understanding of this bacterium's pathobiology, which remains poorly understood. A. baumannii is regarded as an extracellular opportunistic pathogen. However, research on Acinetobacter has largely focused on common lab strains, such as ATCC 19606, that have been isolated several decades ago. These strains exhibit reduced virulence when compared to recently isolated clinical strains. In this work, we demonstrate that, unlike ATCC 19606, several modern A. baumannii clinical isolates, including the recent clinical urinary isolate UPAB1, persist and replicate inside macrophages within spacious vacuoles. We show that intracellular replication of UPAB1 is dependent on a functional type I secretion system (T1SS) and pAB5, a large conjugative plasmid that controls the expression of several chromosomally-encoded genes. Finally, we show that UPAB1 escapes from the infected macrophages by a lytic process. To our knowledge, this is the first report of intracellular growth and replication of A. baumannii. We suggest that intracellular replication within macrophages may contribute to evasion of the immune response, dissemination, and antibiotic tolerance of A. baumannii.